MedPath

HAFIZ MUHAMMAD ASIF

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

Clinical Evaluation of Polyherbal Coded Formulation Obesecure for Leptin Regulation and Obesity Management

Phase 2
Completed
Conditions
Leptin Deficiency
Obesity
Interventions
First Posted Date
2020-06-23
Last Posted Date
2020-06-23
Lead Sponsor
Hafiz Muhammad Asif
Target Recruit Count
132
Registration Number
NCT04443790
Locations
🇵🇰

clinical trial was conducted in Karachi,Islamabad and Faisalabad, Karachi, Punjab, Pakistan

Quadruple and Phytomedicine-based Therapies in H. Pylori Infection

Phase 2
Completed
Conditions
Helicobacter Pylori [H. Pylori] as the Cause of Diseases
Interventions
Drug: Quadruple Allopathic therapy
Drug: Pylorex plus
First Posted Date
2013-12-09
Last Posted Date
2013-12-09
Lead Sponsor
Hafiz Muhammad Asif
Target Recruit Count
176
Registration Number
NCT02004197
Locations
🇵🇰

clinical trial was conducted in high risk areas of Pakistan such as Karachi, Bahawalpur, Islamabad and Rawalpindi at Shifa-Ul-Mulk Memorial Hospital, Hamdrad University Karachi, Bahawalpur Victoria Hospital and Nawaz Salik Hospital respectively, Karachi, Pakistan

🇵🇰

Shifa Ul MUlk Memorial Hospital, Karachi, Pakistan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.